Mani Foroohar

Mani Foroohar

Analyst-Equity på
Leerink Partners LLC
Finance
Consumer Services

Profil

Dr. Mani Foroohar is a Senior Managing Director of Genetic Medicines at Leerink Partners LLC.
He is also a Senior Research Analyst within the Therapeutics team focusing on Genetic Medicines.
Dr. Foroohar joins Leerink from Aptigon Capital, a Citadel Company, where he most recently was a Therapeutics Analyst focused on U.S.
and EU biotechnology, major pharmaceuticals and specialty pharmaceuticals sectors.
Prior to Aptigon, he was an Analyst at Green Owl Capital Management and an Assistant Vice President of Equity Research at Barclays.
In 2013, he co-founded Cellanyx Diagnostics, a company developing a proprietary live tumor cell, phenotypic platform for precision risk stratification in cancer to inform clinical treatment decision making.
Dr. Foroohar holds an M.D.
from Stanford, where he was a Howard Hughes Medical Institute Research Fellow in the Department of Genetics, M.B.A. from Columbia, and a B.S.
from UCLA.

Aktiva positioner av Mani Foroohar

FöretagPositionStart
Analyst-Equity 2018-05-01

Tidigare kända positioner av Mani Foroohar

FöretagPositionSlut
Analyst-Equity 2014-12-01
Analyst-Equity -
Se detaljerna i Mani Foroohars erfarenhet

Mani Foroohars utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

100 +

Första gradens relationer

6

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag6

Finance

Finance

Consumer Services

Finance

Consumer Services

Consumer Services

  1. Börsen
  2. Insiders
  3. Mani Foroohar